• Target：
• ANGPTL3

• Fields：
• >>Cholesterol metabolism

• Gene Name：
• ANGPTL3 ANGPT5 UNQ153/PRO179

• Protein Name：
• ANGPTL3

• Human Gene Id：
• 27329

• Human Swiss Prot No：
• Q9Y5C1

• Mouse Gene Id：
• 30924

• Mouse Swiss Prot No：
• Q9R182

• Immunogen：
• Synthesized peptide derived from human ANGPTL3 AA range: 50-130

• Specificity：
• This antibody detects endogenous levels of Human ANGPTL3

• Formulation：
• Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

• Source：
• Polyclonal, Rabbit,IgG

• Dilution：
• WB 1:1000-2000 ELISA 1:5000-20000

• Purification：
• The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

• Concentration：
• 1 mg/ml

• Storage Stability：
• -15°C to -25°C/1 year(Do not lower than -25°C)

• Other Name：
• Angiopoietin-related protein 3 (Angiopoietin-5;ANG-5;Angiopoietin-like protein 3)

• Molecular Weight(Da)：
• 51kD

• Background：
• similarity:Contains 1 fibrinogen C-terminal domain.,tissue specificity:Expressed principally in liver. Weakly expressed in kidney.,

• Function：
• blood vessel development, vasculature development, glycerol metabolic process, fatty acid metabolic process,phospholipid metabolic process, cell adhesion, cell-matrix adhesion, cell surface receptor linked signal transduction,integrin-mediated signaling pathway, steroid metabolic process, cholesterol metabolic process, phospholipid catabolic process, regulation of catabolic process, positive regulation of catabolic process, regulation of phospholipase activity,negative regulation of phospholipase activity, lipid localization, lipid catabolic process, sterol metabolic process,regulation of lipid metabolic process, alditol metabolic process, organophosphate metabolic process, polyol metabolic process, lipid storage, biological adhesion, regulation of cell migration, positive regulation of cell migration, cell-substrate adhesion, regulation of locomotion, positive regulation of locomotion, 

• Subcellular Location：
• Secreted . Cell projection, lamellipodium . Colocalized with HSPG2 and activated ITGB3 on podocytes. .

• Expression：
• Expressed principally in liver. Weakly expressed in kidney. Binds to adipocytes. Increased expression and colocalization with activated ITGB3 in glomeruli of patients with nephrotic syndrome showing effaced podocyte foot processes (at protein level).

• June 19-2018
• WESTERN IMMUNOBLOTTING PROTOCOL

• June 19-2018
• IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL

• June 19-2018
• IMMUNOFLUORESCENCE PROTOCOL

• September 08-2020
• FLOW-CYTOMEYRT-PROTOCOL

• May 20-2022
• Cell-Based ELISA│解您多样本WB检测之困扰

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN

• July 13-2018
• CELL-BASED-COLORIMETRIC-ELISA-PROTOCOL-FOR-TOTAL-PROTEIN

• July 13-2018
• Antibody-FAQs